Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Hwey Chiu

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Breast Cancer (Dove Medical Press)|March 18, 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by ImmunohistochemistryYi-Fang Tsai, Chih-Yi Hsu, Yun-Ning Chiu, et al.
BMC Cancer|February 26, 2021
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Analytical Biochemistry|February 20, 2007
Evaluation of anti-Fas ligand-induced apoptosis and neural differentiation of PC12 cells treated with nerve growth factor using small interfering RNA method and sampling by microdialysisShih-Hwa Chiou, Chung-Lan Kao, Yu-Lih Chang, et al.
The American Journal of Chinese Medicine|May 14, 2015
A clinical study of integrating acupuncture and Western medicine in treating patients with Parkinson's diseaseFang-Pey Chen, Ching-Mao Chang, Jing-Huei Shiu, et al.
Integrative Cancer Therapies|February 15, 2014
In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With TamoxifenJiun-Liang Chen, Chun-Ju Chang, Jir-You Wang, et al.
Histopathology|December 6, 2018
HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancerYi-Fang Tsai, Ling-Ming Tseng, Pei-Ju Lien, et al.
Cancer Research and Treatment|December 11, 2025
ITGB2 Gene Gain as a Prognostic Marker for Early Recurrence in Luminal HER2-Negative High Proliferative Breast CancerChun-Yu Liu, Ji-Lin Chen, Yi-Fang Tsai, et al.
World Journal of Oncology|January 24, 2025
Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical OutcomesYi-Fang Tsai, Jiun-I Lai, Chun-Yu Liu, et al.
International Journal of Molecular Sciences|January 27, 2024
Genomic Alterations of Tumors in HER2-Low Breast CancersYi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, et al.
Brain, Behavior, and Immunity|June 15, 2011
Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease miceJen-Lin Yang, Jay S C Chen, Yi-Fei Yang, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Breast Cancer (Dove Medical Press)|March 18, 2025
Genetic Alterations in HER2-Positive and Equivocal Breast Cancer by ImmunohistochemistryYi-Fang Tsai, Chih-Yi Hsu, Yun-Ning Chiu, et al.
BMC Cancer|February 26, 2021
Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analysesChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Analytical Biochemistry|February 20, 2007
Evaluation of anti-Fas ligand-induced apoptosis and neural differentiation of PC12 cells treated with nerve growth factor using small interfering RNA method and sampling by microdialysisShih-Hwa Chiou, Chung-Lan Kao, Yu-Lih Chang, et al.
The American Journal of Chinese Medicine|May 14, 2015
A clinical study of integrating acupuncture and Western medicine in treating patients with Parkinson's diseaseFang-Pey Chen, Ching-Mao Chang, Jing-Huei Shiu, et al.
Integrative Cancer Therapies|February 15, 2014
In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With TamoxifenJiun-Liang Chen, Chun-Ju Chang, Jir-You Wang, et al.
Histopathology|December 6, 2018
HER2 immunohistochemical scores provide prognostic information for patients with HER2-type invasive breast cancerYi-Fang Tsai, Ling-Ming Tseng, Pei-Ju Lien, et al.
Cancer Research and Treatment|December 11, 2025
ITGB2 Gene Gain as a Prognostic Marker for Early Recurrence in Luminal HER2-Negative High Proliferative Breast CancerChun-Yu Liu, Ji-Lin Chen, Yi-Fang Tsai, et al.
World Journal of Oncology|January 24, 2025
Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical OutcomesYi-Fang Tsai, Jiun-I Lai, Chun-Yu Liu, et al.
International Journal of Molecular Sciences|January 27, 2024
Genomic Alterations of Tumors in HER2-Low Breast CancersYi-Fang Tsai, Chi-Cheng Huang, Chih-Yi Hsu, et al.
Brain, Behavior, and Immunity|June 15, 2011
Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease miceJen-Lin Yang, Jay S C Chen, Yi-Fei Yang, et al.
Pageof 12